Document Type : Original Research

Authors

Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil Iran

Abstract

Background & Objective: Carbapenem-resistant is Gram-negative bacteria representing a worldwide public health problem. The present study aims to survey the phenotypic and genotypic characteristics of carbapenem-resistant Escherichia coli isolates collected from hospitalized patients and outpatients in Ardabil province, Iran.
Methods: Two hundred samples were collected from the patients who had already been referred to the hospitals in Ardabil, Iran, from January to June 2017. Each patient's social and demographic data were recorded in the first step. The resistance profile of all E. coli isolates against imipenem and meropenem antibiotics were determined using the Kirby-Bauer disk diffusion method. Moreover, the broth microdilution method determined the Minimum Inhibitory Concentration (MIC) of E. coli isolates to imipenem. The Carbapenem Inactivation Method (CIM) and Carba NP test were employed for screening carbapenem-resistant strains. The frequency of carbapenem-encoding genes was determined using Polymerase Chain Reaction (PCR) method. The Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR analysis was used to evaluate the genetic relatedness of E. coli isolates.
Results: Out of 200 urine samples, 66% (n = 132) of the samples were collected from women. The patients' age varied from 1 month to 93 years. Results of the disk diffusion method revealed that 33% (n=66/200) of E. coli isolates were resistant to imipenem. However, imipenem resistance was detected in 37% (n = 74/200) of the E. coli isolates using broth microdilution method. All E. coli isolates were negative in CIM and Carba NP tests. Moreover, we could not detect any carbapenemase encoding genes among E. coli isolates. The ERIC-PCR method revealed the E. coli strains were classified into 39 clusters with 80% similarity.
Conclusion: It appears that E. coli is the most common cause of urinary tract infection in Ardabil province.

Keywords

Main Subjects

  1. Doi Y, Paterson DL, editors. Carbapenemase-producing Enterobacteriaceae. Seminars in respiratory and critical care medicine; 2015: Thieme Medical Publishers. [DOI:10.1055/s-0035-1544208] [PMID] [PMCID]
  2. El-Gamal MI, Brahim I, Hisham N, Aladdin R, Mohammed H, Bahaaeldin A. Recent updates of carbapenem antibiotics. Eur J Med Chem. 2017; 131:185-95. [DOI:10.1016/j.ejmech.2017.03.022] [PMID]
  3. Madec J-Y, Haenni M, Nordmann P, Poirel L. Extended-spectrum β-lactamase/AmpC-and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans? Clin Microbiol Infect. 2017;23(11):826-33. [DOI:10.1016/j.cmi.2017.01.013] [PMID]
  4. Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL. Treating infections caused by carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect. 2014;20(9):862-72. [DOI:10.1111/1469-0691.12697] [PMID]
  5. Seyfi B, Hossainpour H, Kooti S, Azizi Jalilian F. Identification of Carbapenem Resistance Genes in Escherichia coli Isolated from Blattella germanica by Dot Blot Assay in Hamadan Hospitals, Iran - 2018. Iran J Med Microbiol. 2022;16(4):357-62. [DOI:10.30699/ijmm.16.4.357]
  6. Michel-Briand Y. [Resistance to the latest beta-lactams: mechanisms of acquisition and spread of resistance in Enterobacteriaceae]. Bull Acad Natl Med. 2007;191(1):35-50; discussion -1.
  7. Wilson H, Török ME. Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae. Microb Genom. 2018;4(7):e000197. [DOI:10.1099/mgen.0.000197]
  8. Kot B. Antibiotic Resistance Among Uropathogenic Escherichia coli. Pol J Microbiol. 2019;68(4):403-415. [DOI:10.33073/pjm-2019-048] [PMID] [PMCID]
  9. Spaulding CN, Klein RD, Ruer S, Kau AL, Schreiber HL, Cusumano ZT, et al. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist. Nature. 2017;546(7659):528-32. [DOI:10.1038/nature22972] [PMID] [PMCID]
  10. Poirel L, Madec JY, Lupo A, Schink AK, Kieffer N, Nordmann P, et al. Antimicrobial Resistance in Escherichia coli. Microbiol Spectr. 2018;6(4):6.4. 14. [DOI:10.1128/microbiolspec.ARBA-0026-2017] [PMID]
  11. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clinical Infectious Diseases. 2021;72(7):e169-e83. [DOI:10.1093/cid/ciaa1478] [PMID]
  12. Azimi T, Azimi L, Fallah F, Pourmand MR, Ostadtaghizadeh A, Abai MR, et al. detection and characterization of Enterobacteriaceae family members carried by commensal Rattus norvegicus from Tehran, Iran. Arch Microbiol. 2021; 203(4):1321-34. [DOI:10.1007/s00203-020-02126-0] [PMID]
  13. Sahu C, Jain V, Mishra P, Prasad KN. Clinical and laboratory standards institute versus European committee for antimicrobial susceptibility testing guidelines for interpretation of carbapenem antimicrobial susceptibility results for Escherichia coli in urinary tract infection (UTI). J Lab Physicians. 2018;10(3):289-93. [PMID] [PMCID] [DOI:10.4103/JLP.JLP_176_17]
  14. Sfeir MM, Hayden JA, Fauntleroy KA, Mazur C, Johnson JK, Simner PJ, et al. EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-beta-Lactamase-Producing Enterobacteriaceae. J Clin Microbiol. 2019;57(5):e01757-18. [DOI:10.1128/JCM.01757-18] [PMID] [PMCID]
  15. Kim J, Choi O, Kim TS. An Outbreak of Onion Center Rot Caused by Pantoea ananatis in Korea. Plant Dis. 2012;96(10):1576. [DOI:10.1094/PDIS-03-12-0251-PDN] [PMID]
  16. Zhang LP, Xue WC, Meng DY. First report of New Delhi metallo-beta-lactamase 5 (NDM-5)-producing Escherichia coli from blood cultures of three leukemia patients. Int J Infect Dis. 2016;42:45-6. [DOI:10.1016/j.ijid.2015.10.006] [PMID]
  17. Shahandeh Z, Sadighian F, Kalantrai N. Prevalence Escherichia coli, Klebsiella and Enterobacter Species and AmpC-producing Enterobacteriaceae in Clinical Specimens of Hospitals Affiliated to Babol University of Medical Sciences, Iran using Phenotypic and Molecular Methods. Iran J Med Microbiol. 2022; 16 (3):212-220. [DOI: 30699/ijmm.16.3.212 ]
  18. Goncalves GB, Furlan JPR, Vespero EC, Pelisson M, Stehling EG, Pitondo-Silva A. Spread of multidrug-resistant high-risk Klebsiella pneumoniae clones in a tertiary hospital from southern Brazil. Infect Genet Evol. 2017;56:1-7. [DOI:10.1016/j.meegid.2017.10.011] [PMID]
  19. Kiaei S, Moradi M, Hosseini-Nave H, Ziasistani M, Kalantar-Neyestanaki D. Endemic dissemination of different sequence types of carbapenem-resistant Klebsiella pneumoniae strains harboring blaNDM and 16S rRNA methylase genes in Kerman hospitals, Iran, from 2015 to 2017. Infect Drug Resist. 2019;12:45. [DOI:10.2147/IDR.S186994] [PMID] [PMCID]
  20. Thaller MC, Berlutti F, Schippa S, Iori P, Passariello C, Rossolini GM. Heterogeneous patterns of acid phosphatases containing low-molecular-mass polypeptides in members of the family Enterobacteriaceae. Int J Syst Evol. 1995;45(2):255-61. [DOI:10.1099/00207713-45-2-255]
  21. Kelly AM, Mathema B, Larson EL. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents. 2017;50 (2):127-34. [PMID] [PMCID] [DOI:10.1016/j.ijantimicag.2017.03.012]
  22. Gomes TA, Elias WP, Scaletsky IC, Guth BE, Rodrigues JF, Piazza RM, et al. Diarrheagenic Escherichia coli. Braz J Microbiol. 2016;47 Suppl 1:3-30. [DOI:10.1016/j.bjm.2016.10.015] [PMID] [PMCID]
  23. Ripabelli G, Sammarco ML, Scutellà M, Felice V, Tamburro M. Carbapenem-resistant KPC-and TEM-producing Escherichia coli ST131 isolated from a hospitalized patient with urinary tract infection: first isolation in Molise region, Central Italy, 2018. Microb Drug Resist. 2020;26(1):38-45. [DOI:10.1089/mdr.2019.0085] [PMID]
  24. Murugan MS, Sinha DK, Vinodh Kumar OR, Yadav AK, Pruthvishree BS, Vadhana P, et al. Epidemiology of carbapenem-resistant Escherichia coli and first report of blaVIM carbapenemases gene in calves from India. Epidemiol Infect. 2019;147:e159. [DOI:10.1017/S0950268819000463] [PMID] [PMCID]
  25. Mahmoud NE, Altayb HN, Gurashi RM. Detection of Carbapenem-Resistant Genes in Escherichia coli Isolated from Drinking Water in Khartoum, Sudan. J Environ Public Health. 2020;2020:2571293. [DOI:10.1155/2020/2571293] [PMID] [PMCID]
  26. Gurung S, Kafle S, Dhungel B, Adhikari N, Thapa Shrestha U, Adhikari B, et al. Detection of OXA-48 Gene in Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae from Urine Samples. Infect Drug Resist. 2020;13:2311-21. [DOI:10.2147/IDR.S259967] [PMID] [PMCID]
  27. Azimi L, Fallah F, Karimi A, Shirdoust M, Azimi T, Sedighi I, et al. Survey of various carbapenem-resistant mechanisms of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from clinical samples in Iran. Iran J Basic Med Sci. 2020;23(11):1396.
  28. Azimi T, Maham S, Fallah F, Azimi L, Gholinejad Z. Evaluating the antimicrobial resistance patterns among major bacterial pathogens isolated from clinical specimens taken from patients in Mofid Children's Hospital, Tehran, Iran: 2013-2018. Infect Drug Resist. 2019;12:2089. [DOI:10.2147/IDR.S215329] [PMID] [PMCID]
  29. Fallah F, Azimi T, Azimi L, Karimi A, Rahbar M, Shirdoust M, et al. Evaluating the antimicrobial resistance and frequency of AmpC β-lactamases blaCMY-2 gene in Gram-negative bacteria isolates collected from selected hospitals of Iran: a multicenter retrospective study. Gene Reports. 2020;21:100868. [DOI:10.1016/j.genrep.2020.100868]
  30. Dagher C, Salloum T, Alousi S, Arabaghian H, Araj GF, Tokajian S. Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon. PLoS One. 2018;13(9):e0203323. [DOI:10.1371/journal.pone.0203323] [PMID] [PMCID]
  31. Armin S, Fallah F, Karimi A, Azimi T, Kafil HS, Zahedani SS, et al. Multicentre study of the main carbapenem resistance mechanisms in important members of the Enterobacteriaceae family in Iran. New Microbes New Infect. 2021;41:100860. [DOI:10.1016/j.nmni.2021.100860] [PMID] [PMCID]
  32. Ssekatawa K, Byarugaba DK, Nakavuma JL, Kato CD, Ejobi F, Tweyongyere R, et al. Carbapenem resistance profiles of Pathogenic Escherichia coli in Uganda. 2020. [DOI:10.21203/rs.3.rs-125368/v1]